Hudson Institute of Medical Research

Site

Hudson Institute Cell Therapies

Accreditation No.

21322

Site No.

25678

Date of Accreditation

04 Oct 2024

Address

TRF, Level 4, 27-31 Wright Street
Clayton, VIC 3168
Australia

hudson.org.au

Contact

Dr Mirja Krause P: +61 (03) 85722802

Availability

Services conditionally available to external clients

Supervision

HPS (Haemopoietic processing, storage)

Scope of Accreditation

Hudson Institute Cell Therapies

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsProducts received from AN 21171 SN 25469 Haemopoietic progenitor cells Processing; Storage (includes freezing/thawing)

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.